Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Company Profile
CNTB Connect Biopharma
0.743
+0.008+1.09%
Post Mkt Price
0.7430.0000.00%
Symbol
CNTB
Company Name
Connect Biopharma
Listing Date
03/19/2021
Establishment Date
2015
CEO
Dr. Zheng Wei, PhD
Market
NASDAQ
Employees
108
Securities Type
DR
ADS Ratio
1.0 : 1.0
Fiscal Year Ends
12-31
Address
Science & Technology Park,3/F, East R&D Building,6 Beijing West Road
City
Taicang
Province
Jiangsu
Country
China
Zip code
215400
Phone
86-512-53577866
Profile
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
Company Overview
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist